Article Details
Retrieved on: 2025-01-11 22:49:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley analyst Judah Frommer lowered the firm's price target on 4D Molecular (FDMT) to $6 from $8 and keeps an Underweight rating on the.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here